| Literature DB >> 30508315 |
Louise Giansante1, Juliana C Martins1,2, Denise Y Nersissian1, Karen C Kiers1,3, Fernando U Kay4, Marcio V Y Sawamura4, Choonsik Lee5, Eloisa M M S Gebrim4, Paulo R Costa1.
Abstract
PURPOSE: To evaluate organ doses in routine and low-dose chest computed tomography (CT) protocols using an experimental methodology. To compare experimental results with results obtained by the National Cancer Institute dosimetry system for CT (NCICT) organ dose calculator. To address the differences on organ dose measurements using tube current modulation (TCM) and fixed tube current protocols.Entities:
Keywords: Monte Carlo simulations; computed tomography; dosimetry/exposure assessment; image quality; organ dose
Mesh:
Year: 2018 PMID: 30508315 PMCID: PMC6333138 DOI: 10.1002/acm2.12505
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.102
Figure 1Thermoluminescent dosimeter holder, specially designed to be introduced into RANDO phantom internal holes, and the TLD chips placed beside a scale for perspective view.
Acquisition parameters for the adult phantom irradiation using the GE CT scanner. The values for CTDIvol and DLP displayed by the scanner, relative to a 32 cm CTDI phantom, are also shown
| SPR | Constant tube current | Tube current modulation | ||||
|---|---|---|---|---|---|---|
| Standard | Low dose | Ultra low dose | Auto mA | Auto + Smart mA | ||
| Tube voltage (kV) | 120 | |||||
| Tube current (mA) | 10 | 300 | 120 | 40 | 80–300 | 80–300 |
| Rotation time (s) | – | 0.6 | 0.4 | 0.4 | 0.6 | 0.6 |
| Pitch | – | 1.375 | 1.375 | 1.375 | 1.375 | 1.375 |
| Collimation (mm) | – | 64 × 0.625 | 64 × 0.625 | 64 × 0.625 | 64 × 0.625 | 64 × 0.625 |
| CTDIvol (mGy) | – | 10.03 | 2.76 | 0.92 | 6.61 | 5.59 |
| DLP (mGy cm) | – | 465.90 | 128.52 | 42.81 | 306.96 | 259.49 |
Acquisition parameters for the pediatric phantom irradiation using the Philips CT scanner. The values for CTDIvol and DLP displayed by the scanner, relative to a 32 cm phantom, are also shown
| Chest for children | ||||
|---|---|---|---|---|
| Constant tube current | Longitudinal tube current modulation | |||
| Tube voltage (kV) | 120 | 80 | 120 | 80 |
| Tube current (mA) | 121 | 323 | 66–118 | 168–318 |
| Rotation time (s) | 0.45 | 0.45 | 0.45 | 0.45 |
| Pitch | 0.922 | 0.922 | 0.922 | 0.922 |
| Collimation (mm) | 64 × 0.625 | 64 × 0.625 | 64 × 0.625 | 64 × 0.625 |
| CTDIvol (mGy) | 3.7 | 2.8 | 2.8 | 2.2 |
| DLP (mGy cm) | 103.6 | 76.4 | 85.0 | 65.3 |
TLD groups distributed inside the RANDO Phantom for studied protocols and double SPR, and corresponding lung mass fraction. is the lung fraction contained in slices.25, 33, 34
| Slice |
| Number of TLD groups |
|---|---|---|
| 11 | 0.06 | 2 |
| 12 | 0.09 | 2 |
| 13 | 0.11 | 6 |
| 14 | 0.14 | 6 |
| 15 | 0.14 | 8 |
| 16 | 0.13 | 6 |
| 17 | 0.13 | 4 |
| 18 | 0.11 | 4 |
| 19 | 0.09 | 2 |
TLD groups distributed inside the CIRS ATOM Phantom for all studied chest protocols, and corresponding organ mass fractions.32
| Slice ( | Organ |
| Number of TLD groups |
|---|---|---|---|
| 8 | Thyroid | 1.00 | 4 |
| 9 | Lungs | 0.02 | 2 |
| 10 | 0.14 | 4 | |
| 11 | 0.19 | 6 | |
| 12 | 0.22 | 6 | |
| 13 | 0.23 | 8 | |
| 14 | 0.17 | 4 | |
| 15 | 0.03 | 2 |
Mass‐energy absorption coefficients obtained for each compound and applied to estimate the organ doses
|
|
|
| ||
|---|---|---|---|---|
|
| 120 kV | 0.0365 | 0.0402 | 0.0339 |
| 80 kV | 0.0557 | 0.0610 | 0.0521 |
Figure 2Five most applied CT protocols for pediatric (left) and adult (right) patients at InRad during the years 2014–2016. Chest CT is the 5th most applied protocol in pediatric patients and the 4th most applied protocol in adult patients.
Lung‐absorbed doses and further dosimetric quantities with respective uncertainties (k = 1) for the Chest protocols applied to the adult phantom
| SPR | Chest protocols — constant tube current | Chest protocols — tube current modulation/TCM | ||||
|---|---|---|---|---|---|---|
| Standard | Low dose | Ultra low dose | Auto mA | Auto + Smart mA | ||
| Dose/mAs (mGy/mAs) | – | 0.0794 ± 0.0009 | 0.081 ± 0.001 | 0.078 ± 0.001 | – | – |
| Dose/mAseff (mGy/mAseff) | – | 0.109 ± 0.001 | 0.111 ± 0.001 | 0.107 ± 0.001 | – | – |
| Lung mean absorbed dose (mGy) | 0.19 ± 0.01 | 14.30 ± 0.70 | 3.88 ± 0.19 | 1.24 ± 0.06 | 11.90 ± 0.60 | 9.29 ± 0.46 |
Organ‐absorbed doses and further dosimetric quantities with respective uncertainties (k = 1) for the Chest protocols applied to the pediatric phantom
| Chest for children protocol | ||||
|---|---|---|---|---|
| Constant tube current | Longitudinal tube current modulation | |||
| Thyroid | ||||
| Dose/mAs (mGy/mAs) | 0.124 ± 0.004 | 0.041 ± 0.002 | – | – |
| Dose/mAseff (mGy/mAseff) | 0.115 ± 0.004 | 0.037 ± 0.002 | – | – |
| Mean absorbed dose (mGy) | 6.84 ± 0.25 | 5.93 ± 0.31 | 4.05 ± 0.25 | 3.02 ± 0.13 |
| Lungs | ||||
| Dose/mAs (mGy/mAs) | 0.111 ± 0.005 | 0.030 ± 0.001 | – | – |
| Dose/mAseff (mGy/mAseff) | 0.113 ± 0.005 | 0.027 ± 0.001 | – | – |
| Mean absorbed dose (mGy) | 6.12 ± 0.27 | 4.58 ± 0.22 | 5.13 ± 0.23 | 3.66 ± 0.16 |
Comparative evaluation between experimental and simulated organ doses for the adult and pediatric phantom
| Adult lung doses | ||||||
|---|---|---|---|---|---|---|
| Organ | Measurement | Chest protocols — constant tube current | Chest protocols — tube current modulation/TCM | |||
| Standard | Low‐dose | Ultra low‐dose | Auto mA | Auto + Smart mA | ||
| Lungs | TLD (mGy) | 14.30 ± 0.72 | 3.88 ± 0.19 | 1.24 ± 0.06 | 11.90 ± 0.60 | 9.29 ± 0.46 |
| NCICT (mGy) | 13.24 | 3.64 | 1.21 | 14.11 | 11.23 | |
| Δ (%) | −(8.0 ± 0.9) | −(6.5 ± 0.3) | −(2.1 ± 0.1) | (15.7 ± 0.8) | (17.3 ± 0.9)% | |
Figure 3Bland–Altman plot of the percent differences against the mean of the organ doses obtained with the NCICT software and TLD measurements. The mean of the percent differences is presented in blue (8.9%) and the 95% limits of agreement are presented in the dashed lines.
Lung‐absorbed doses due to the Standard, Low Dose, and Ultra Low‐Dose chest CT protocols estimated by the present work (with TLD measurements) and by the methodology proposed by Huda and Sandison.49 The relative difference was calculated as the percentage difference between the values estimated by both methodologies
| Standard | Low dose | Ultra low dose | |
|---|---|---|---|
| Dose by TLD measurements (mGy) | 14.3 ± 0.2 | 3.88 ± 0.19 | 1.24 ± 0.06 |
| CTDIvol (mGy) | 10.03 | 2.76 | 0.92 |
| Dose by Huda et al. | 15.0 ± 0.6 | 4.1 ± 0.2 | 1.38 ± 0.06 |
| Relative difference (%) | 4.7 ± 4.0 | 5.4 ± 4.8 | 10.1 ± 4.1 |
Comparison among absorbed doses for thyroid and lungs when using fixed mA with 120 and 80 kV
| Dose (mGy) | |||
|---|---|---|---|
| 120 kV, 55 mAs | 80 kV, 146 mAs | Percent decrease | |
| Thyroid | 6.84 ± 0.25 | 5.93 ± 0.31 | 13.3 ± 0.8% |
| Lungs | 6.12 ± 0.27 | 4.58 ± 0.22 | 25.2 ± 1.6% |
The absorbed doses for thyroid and lungs when using fixed mA and TCM with 120 and 80 kV
| 120 kV, 55 mAs | 120 kV, 30–54 mAs (TCM) | Percent decrease (%) | |
|---|---|---|---|
| Thyroid | 6.84 ± 0.25 | 4.05 ± 0.25 | 40.8 ± 2.9 |
| Lungs | 6.12 ± 0.27 | 5.13 ± 0.23 | 16.2 ± 1.0 |
Figure 4Variation of the tube current‐time product over the longitudinal axis of the patient and the phantom, from the neck (Table position 0) to the abdomen with a tube voltage of 80 and 120 kV. The tube current‐time product decreases in the direction of the abdomen of the phantom and increases in the direction of the abdomen of the patient. In both cases, the area within the black vertical lines corresponds to the position of the lungs inside the phantom, and within the red vertical lines to the position of the lungs inside the patient.